In our case, the patient was an allo-HSCT candidate from the outset (initial diagnosis: Ph-like B-ALL) and remained a candidate after revision to MLN-eo-TK with PCM1::JAK2 rearrangement. The gene discussed is PCM1; the disease is acute lymphoblastic leukemia.